Author: Tabea
-
Poster presentation at ASH 2025 in Orlando
Come and see our posters presented at ASH 2025 in Orlando on December 7, 2025 from 6:00 PM – 8:00 PM: We are looking forward to meet you and hear you thoughts about our online modules! Read more
-
We published a comprehensive review on the management of sickle cell disease in pregnancy.
-
New Article about Alloimunization in Pregnancy
Read the newest “How I treat” about alloimunization in pregnancy published in Blood on May 15th. Read more
-
Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) is a disorder caused by maternal alloantibodies directed against paternally inherited fetal platelet antigens, most commonly human platelet antigen-1a (HPA-1a). These antibodies cross the placenta, leading to fetal thrombocytopenia and an increased risk of intracranial hemorrhage and other bleeding complications. Rallybio has announced on April 8th to discontinue the… Read more
-
The Homepage is online!
Finally, the homepage obstetric-hematology.com is online! I am excited about this project, which aims to improve the availability of resources, the education of clinicians, and ultimately, patient care for women with hematologic disorders. Read more